Melatonin Cream Against Acute Radiation Dermatitis in Patients With Early Breast Cancer
Status:
Completed
Trial end date:
2021-01-31
Target enrollment:
Participant gender:
Summary
The aim of the present randomized double-blinded placebo-controlled clinical trial is to
investigate if melatonin can protect against acute radiation dermatitis in patients with
early breast cancer receiving radiation therapy, and whether this has an impact on the
patients' quality of life.